+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
At-home Drug of Abuse Testing Market - Global Forecast 2026-2032- Product Image
At-home Drug of Abuse Testing Market - Global Forecast 2026-2032- Product Image
New

At-home Drug of Abuse Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5716235
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The at-home drug of abuse testing market is advancing rapidly, shaped by the convergence of digital technology, regulatory scrutiny, and shifting consumer and clinical expectations. The sector now plays an integral role across healthcare, occupational health, and individual wellness channels as stakeholders seek efficient, private, and clinically reliable diagnostic solutions.

Market Snapshot: At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market expanded from USD 3.10 billion in 2025 to USD 3.33 billion in 2026, maintaining a compound annual growth rate (CAGR) of 7.40%. The market is projected to reach USD 5.11 billion by 2032. This growth reflects a sustained rise in demand driven by digital diagnostics and the decentralization of healthcare delivery, with adoption strong among clinics, occupational health programs, retailers, and end consumers.

Scope & Segmentation

  • Distribution Channels: Includes e-commerce platforms, manufacturer direct sales, chain pharmacies, and independent pharmacy outlets. Each pathway presents unique fulfillment models and customer engagement strategies.
  • Test Types: Multi-drug panels (such as five-panel, ten-panel, or three-panel kits) and single-drug assays for specific substances including amphetamines, cocaine, marijuana, and opiates.
  • Sample Matrices: Analysis via hair, saliva, sweat, and urine. Saliva tests are further divided into oral fluid dip cards and swabs, affecting ease of use and analytical sensitivity.
  • Technology Modalities: Chromatography (gas and liquid chromatography-mass spectrometry), immunoassays (competitive and sandwich formats), and lateral flow (conventional and digital readout options).
  • End-user Segments: Encompasses clinics (such as occupational health and substance abuse centers), pharmacies (both chain and independent), and individual consumers, each with distinct usage drivers and regulatory considerations.
  • Geographical Regions: Americas, Europe, Middle East & Africa (EMEA), and Asia-Pacific, each region reflecting unique regulatory frameworks, consumer preferences, and supply chain models.

Key Takeaways

  • Technological innovation is redefining product capabilities, with digital readouts and remote verification increasing result accuracy and interpretability for both consumers and clinicians.
  • Regulatory pressures have intensified, driving manufacturers to strengthen traceability, validation, and clear user instructions, supporting compliance across global markets and long-term adoption in both clinical and occupational health settings.
  • Retail, e-commerce, and direct manufacturer channels now offer differentiated access points, contributing to both market expansion and the need for tailored pricing and customer support strategies.
  • Improved interoperability with telehealth platforms and electronic health records is accelerating home-based diagnostics as an extension of clinical care, supporting ongoing patient monitoring and follow-up.
  • Stakeholders must carefully coordinate R&D, commercial, and regulatory actions to ensure product credibility and sustainability, particularly in the face of evolving compliance and data privacy standards.

Tariff Impact: United States 2025

Tariffs enacted in the United States in 2025 introduced significant cost and operational pressures throughout the at-home drug testing supply chain. Increased input costs and longer lead times, particularly for imported components such as assay reagents and electronic modules, prompted manufacturers to pursue dual-sourcing and nearshoring strategies. Distributors responded by adjusting inventory management and prioritizing domestic suppliers, while clinical buyers increased scrutiny over procurement transparency and supply chain resilience. Regulatory compliance and quality assurance remained central, leading to greater investment in vendor audits and supply traceability as firms adapted to heightened market volatility.

Methodology & Data Sources

This market analysis synthesizes multi-source evidence through systematic secondary research—including regulatory documents, scientific literature, and industry filings—combined with structured interviews of clinicians, procurement leaders, laboratory partners, and distribution managers. Analytical frameworks integrated thematic analysis with supply mapping and scenario risk assessments, ensuring findings align with practical realities and reflect unbiased, robust insights.

Why This Report Matters

  • Supports strategic initiatives by detailing evolving distribution models and compliance priorities in the at-home drug of abuse testing sector.
  • Delivers actionable intelligence on segmentation dynamics—from test technologies and sample collection to channel strategies and supply chain agility.
  • Enables decision-makers to benchmark organizational planning against emerging risks, regional diversity, and regulatory shifts.

Conclusion

Significant shifts in technology, regulation, and commercial models are reshaping the at-home drug of abuse testing market. Strategic alignment across R&D, quality, and commercial functions will be essential for sustained leadership and effective market expansion.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. At-home Drug of Abuse Testing Market, by Distribution Channel
8.1. Online
8.1.1. Ecommerce Platforms
8.1.2. Manufacturer Websites
8.2. Pharmacy Retail
8.2.1. Chain Pharmacy
8.2.2. Independent Pharmacy
9. At-home Drug of Abuse Testing Market, by Test Type
9.1. Multi-Drug Panel
9.1.1. Five Panel
9.1.2. Ten Panel
9.1.3. Three Panel
9.2. Single Drug
9.2.1. Amphetamines
9.2.2. Cocaine
9.2.3. Marijuana
9.2.4. Opiates
10. At-home Drug of Abuse Testing Market, by Sample Type
10.1. Hair
10.2. Saliva
10.2.1. Oral Fluid Dip Card
10.2.2. Saliva Swab
10.3. Sweat
10.4. Urine
11. At-home Drug of Abuse Testing Market, by Technology
11.1. Chromatography
11.1.1. Gas Chromatography-Mass Spectrometry
11.1.2. Liquid Chromatography-Mass Spectrometry
11.2. Immunoassay
11.2.1. Competitive
11.2.2. Sandwich
11.3. Lateral Flow
11.3.1. Conventional
11.3.2. Digital
12. At-home Drug of Abuse Testing Market, by End User
12.1. Clinics
12.1.1. Occupational Programs
12.1.2. Substance Abuse Clinics
12.2. Individuals
12.3. Pharmacies
12.3.1. Chain
12.3.2. Independent
13. At-home Drug of Abuse Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. At-home Drug of Abuse Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. At-home Drug of Abuse Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States At-home Drug of Abuse Testing Market
17. China At-home Drug of Abuse Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. AccuQuik Test Kits
18.7. ACON Laboratories Inc.
18.8. Alere Inc.
18.9. American Screening Corporation
18.10. Bio-Rad Laboratories Inc.
18.11. Chembio Diagnostic Systems Inc.
18.12. Confirm Biosciences Inc.
18.13. First Check Diagnostics LLC
18.14. Laboratory Corporation of America Holdings
18.15. Medtox Laboratories Inc.
18.16. OraSure Technologies Inc.
18.17. PDC Healthcare
18.18. Premier Biotech Inc.
18.19. Psychemedics Corporation
18.20. Quest Diagnostics Incorporated
18.21. Redwood Toxicology Laboratory Inc.
18.22. Siemens Healthineers
18.23. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY THREE PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY THREE PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY THREE PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID DIP CARD, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID DIP CARD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID DIP CARD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA SWAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA SWAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OCCUPATIONAL PROGRAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OCCUPATIONAL PROGRAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OCCUPATIONAL PROGRAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBSTANCE ABUSE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBSTANCE ABUSE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBSTANCE ABUSE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDIVIDUALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDIVIDUALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 196. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 197. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 198. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 199. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 200. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 202. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 204. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 205. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 206. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 208. EUROPE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 225. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 228. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 229. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 230. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 231. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 232. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 233. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 234. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 236. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 237. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 238. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 240. AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 261. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 262. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 263. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 264. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 265. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 266. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 267. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 269. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 270. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 271. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 273. ASEAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 274. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 276. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 277. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 278. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 279. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 280. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 281. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 282. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 283. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 285. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 286. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 287. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 289. GCC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION AT-HOME DRUG OF ABUSE TESTING MARKET

Companies Mentioned

The key companies profiled in this At-home Drug of Abuse Testing market report include:
  • Abbott Laboratories
  • AccuQuik Test Kits
  • ACON Laboratories Inc.
  • Alere Inc.
  • American Screening Corporation
  • Bio-Rad Laboratories Inc.
  • Chembio Diagnostic Systems Inc.
  • Confirm Biosciences Inc.
  • First Check Diagnostics LLC
  • Laboratory Corporation of America Holdings
  • Medtox Laboratories Inc.
  • OraSure Technologies Inc.
  • PDC Healthcare
  • Premier Biotech Inc.
  • Psychemedics Corporation
  • Quest Diagnostics Incorporated
  • Redwood Toxicology Laboratory Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.11 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Point Of Care Drug Of Abuse Testing Market Size, Share & Trends Analysis Report By Product (Immunoassay Test Strips And Cassettes, Oral Fluid Testing Kits), By Sample Type, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Point Of Care Drug Of Abuse Testing Market Size, Share & Trends Analysis Report By Product (Immunoassay Test Strips And Cassettes, Oral Fluid Testing Kits), By Sample Type, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 136 Pages
  • Global
From
Drug of Abuse Testing Market - Global Forecast 2026-2032 - Product Image

Drug of Abuse Testing Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 220 Pages
  • Global
From
Drugs of Abuse Testing - Global Strategic Business Report - Product Image

Drugs of Abuse Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.